Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Oct;107(2):577–583. doi: 10.1111/j.1476-5381.1992.tb12786.x

Lack of effect of the antimigraine drugs, sumatriptan, ergotamine and dihydroergotamine on arteriovenous anastomotic shunting in the dura mater of the pig.

M O den Boer 1, J A Somers 1, P R Saxena 1
PMCID: PMC1907860  PMID: 1330188

Abstract

1. In anaesthetized animals, the antimigraine drugs, sumatriptan, ergotamine and dihydroergotamine, reduce carotid arteriovenous anastomotic shunting. Within the carotid vascular bed arteriovenous anastomoses are located, amongst other places in the dura mater, which is a putative site of the pain during a migraine attack. 2. In this investigation, we have localized and measured the arteriovenous shunting within the carotid vascular bed of the pig by using simultaneous intracarotid injections of radiolabelled microspheres of three different sizes (10, 15 and 50 microns), which provides an index of blood flow via arteriovenous anastomoses larger than approximately 14, 27 and 90 microns diameter, respectively. The effects of sumatriptan (0.3 mg kg-1), ergotamine (0.02 mg kg-1), dihydroergotamine (0.1 mg kg-1) and saline were studied by repeating the injections of 15 and 50 microns spheres after the treatments. 3. There was no difference in shunting or entrapment between the 10 and 15 microns microsphere, indicating the absence of arteriovenous anastomoses with a diameter between 14 and 27 microns. 4. Arteriovenous anastomoses with a diameter between 27 and 90 microns, as indicated by the difference in blood flow measured by 15 and 50 microns spheres, were located in the dura mater, ears, skin, fat and, to a lesser extent, in the skeletal muscles and eyes. 5. Sumatriptan, ergotamine and dihydroergotamine reduced the overall flow in the smaller arteriovenous anastomoses (diameter between 27 and 90 microns), and even more in larger shunts (wider than 90 microns). 6. Locally, blood flow in the smaller arteriovenous shunts was reduced in the skin and fat, but not in the dura mater, ears, eyes and muscles.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
577

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bom A. H., Heiligers J. P., Saxena P. R., Verdouw P. D. Reduction of cephalic arteriovenous shunting by ergotamine is not mediated by 5-HT1-like or 5-HT2 receptors. Br J Pharmacol. 1989 Jun;97(2):383–390. doi: 10.1111/j.1476-5381.1989.tb11965.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Buzzi M. G., Moskowitz M. A. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol. 1990 Jan;99(1):202–206. doi: 10.1111/j.1476-5381.1990.tb14679.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dickhoner W. H., Bradley B. R., Harell G. S. Diameter of arterial microvessels trapping 8--10 micron, 15 micron and 25 micron microspheres as determined by vital microscopy of the hamster cheek pouch. Invest Radiol. 1978 Jul-Aug;13(4):313–317. doi: 10.1097/00004424-197807000-00007. [DOI] [PubMed] [Google Scholar]
  4. Faraci F. M., Kadel K. A., Heistad D. D. Vascular responses of dura mater. Am J Physiol. 1989 Jul;257(1 Pt 2):H157–H161. doi: 10.1152/ajpheart.1989.257.1.H157. [DOI] [PubMed] [Google Scholar]
  5. Forsyth R. P., Hoffbrand B. I. Redistribution of cardiac output after sodium pentobarbital anesthesia in the monkey. Am J Physiol. 1970 Jan;218(1):214–217. doi: 10.1152/ajplegacy.1970.218.1.214. [DOI] [PubMed] [Google Scholar]
  6. Friberg L., Olesen J., Iversen H. K., Sperling B. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet. 1991 Jul 6;338(8758):13–17. doi: 10.1016/0140-6736(91)90005-a. [DOI] [PubMed] [Google Scholar]
  7. Goadsby P. J., Edvinsson L., Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990 Aug;28(2):183–187. doi: 10.1002/ana.410280213. [DOI] [PubMed] [Google Scholar]
  8. Humphrey P. P., Feniuk W., Perren M. J., Beresford I. J., Skingle M., Whalley E. T. Serotonin and migraine. Ann N Y Acad Sci. 1990;600:587–600. doi: 10.1111/j.1749-6632.1990.tb16912.x. [DOI] [PubMed] [Google Scholar]
  9. Humphrey P. P., Feniuk W., Perren M. J., Connor H. E., Oxford A. W., Coates L. H., Butina D. GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein. Br J Pharmacol. 1988 Aug;94(4):1123–1132. doi: 10.1111/j.1476-5381.1988.tb11630.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kaihara S., Van Heerden P. D., Migita T., Wagner H. N., Jr Measure- ment of distribution of cardiac output. J Appl Physiol. 1968 Dec;25(6):696–700. doi: 10.1152/jappl.1968.25.6.696. [DOI] [PubMed] [Google Scholar]
  11. Kerber C. W., Newton T. H. The macro and microvasculature of the dura mater. Neuroradiology. 1973 Dec;6(4):175–179. doi: 10.1007/BF00335317. [DOI] [PubMed] [Google Scholar]
  12. Markowitz S., Saito K., Moskowitz M. A. Neurogenically mediated plasma extravasation in dura mater: effect of ergot alkaloids. A possible mechanism of action in vascular headache. Cephalalgia. 1988 Jun;8(2):83–91. doi: 10.1046/j.1468-2982.1988.0802083.x. [DOI] [PubMed] [Google Scholar]
  13. Müller-Schweinitzer E., Rosenthaler J. Dihydroergotamine: pharmacokinetics, pharmacodynamics, and mechanism of venoconstrictor action in beagle dogs. J Cardiovasc Pharmacol. 1987 Jun;9(6):686–693. [PubMed] [Google Scholar]
  14. Olesen J., Friberg L., Olsen T. S., Iversen H. K., Lassen N. A., Andersen A. R., Karle A. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol. 1990 Dec;28(6):791–798. doi: 10.1002/ana.410280610. [DOI] [PubMed] [Google Scholar]
  15. Parsons A. A., Whalley E. T., Feniuk W., Connor H. E., Humphrey P. P. 5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery. Br J Pharmacol. 1989 Feb;96(2):434–440. doi: 10.1111/j.1476-5381.1989.tb11835.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Perren M. J., Feniuk W., Humphrey P. P. The selective closure of feline carotid arteriovenous anastomoses (AVAs) by GR43175. Cephalalgia. 1989;9 (Suppl 9):41–46. doi: 10.1111/J.1468-2982.1989.TB00071.X. [DOI] [PubMed] [Google Scholar]
  17. ROWBOTHAM G. F., LITTLE E. NEW CONCEPTS ON THE AETIOLOGY AND VASCULARIZATION OF MENINGIOMATA; THE MECHANISM OF MIGRAINE; THE CHEMICAL PROCESSES OF THE CEREBROSPINAL FLUID; AND THE FORMATION OF COLLECTIONS OF BLOOD OR FLUID IN THE SUBDURAL SPACE. Br J Surg. 1965 Jan;52:21–24. doi: 10.1002/bjs.1800520105. [DOI] [PubMed] [Google Scholar]
  18. SHERMAN J. L., Jr NORMAL ARTERIOVENOUS ANASTOMOSES. Medicine (Baltimore) 1963 Jul;42:247–267. doi: 10.1097/00005792-196307000-00001. [DOI] [PubMed] [Google Scholar]
  19. Saxena P. R. Arteriovenous shunting and migraine. Res Clin Stud Headache. 1978;6:89–102. [PubMed] [Google Scholar]
  20. Saxena P. R., Den Boer M. O. Pharmacology of antimigraine drugs. J Neurol. 1991;238 (Suppl 1):S28–S35. doi: 10.1007/BF01642903. [DOI] [PubMed] [Google Scholar]
  21. Saxena P. R., Koedam N. A., Heiligers J., Hof R. P. Ergotamine-induced constriction of cranial arteriovenous anastomoses in dogs pretreated with phentolamine and pizotifen. Cephalalgia. 1983 Jun;3(2):71–81. doi: 10.1046/j.1468-2982.1983.0302071.x. [DOI] [PubMed] [Google Scholar]
  22. Saxena P. R., Schamhardt H. C., Forsyth R. P., Hoeve J. Computer programs for the radioactive microsphere technique. Determination of regional blood flows and other haemodynamic variables in different experimental circumstances. Comput Programs Biomed. 1980 Dec;12(2-3):63–84. doi: 10.1016/0010-468x(80)90053-7. [DOI] [PubMed] [Google Scholar]
  23. Saxena P. R., Verdouw P. D. Redistribution by 5-hydroxytryptamine of carotid arterial blood at the expense of arteriovenous anastomotic blood flow. J Physiol. 1982 Nov;332:501–520. doi: 10.1113/jphysiol.1982.sp014427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Saxena P. R., Verdouw P. D. Tissue blood flow and localization of arteriovenous anastomoses in pigs with microspheres of four different sizes. Pflugers Arch. 1985 Feb;403(2):128–135. doi: 10.1007/BF00584089. [DOI] [PubMed] [Google Scholar]
  25. Sleight A. J., Cervenka A., Peroutka S. J. In vivo effects of sumatriptan (GR 43175) on extracellular levels of 5-HT in the guinea pig. Neuropharmacology. 1990 Jun;29(6):511–513. doi: 10.1016/0028-3908(90)90061-u. [DOI] [PubMed] [Google Scholar]
  26. WISLOCKI G. B., LEDUC E. H. Vital staining of the hematoencephalic barrier by silver nitrate and trypan blue, and cytological comparisons of the neurohypophysis, pineal body, area postrema, intercolumnar tubercle and supraoptic crest. J Comp Neurol. 1952 Jun;96(3):371–413. doi: 10.1002/cne.900960302. [DOI] [PubMed] [Google Scholar]
  27. den Boer M. O., Heiligers J. P., Saxena P. R. Carotid vascular effects of ergotamine and dihydroergotamine in the pig: no exclusive mediation via 5-HT1-like receptors. Br J Pharmacol. 1991 Sep;104(1):183–189. doi: 10.1111/j.1476-5381.1991.tb12405.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. den Boer M. O., Villalón C. M., Heiligers J. P., Humphrey P. P., Saxena P. R. Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan. Br J Pharmacol. 1991 Feb;102(2):323–330. doi: 10.1111/j.1476-5381.1991.tb12173.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES